Article
Innovative Clinical Trials: The LUNG-MAP Study.
Clinical pharmacology and therapeutics - 1 May 2015
Steuer C E, Papadimitrakopoulou V, Herbst R S, Redman M W, Hirsch F R, Mack P C, Ramalingam S S, Gandara D R
Abstract excerpt
Although the proportion of patients with squamous cell carcinoma of the lung has declined over the last two decades, the disease is still fatal for tens of thousands of patients each year. The treatment of non-small cell lung cancer has advanced rapidly over the past decade, providing novel, targeted therapeutic options to patients, but has mostly been limited to the adenocarcinoma histology. Efforts are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.